NEW YORK (GenomeWeb News) - NextGen Sciences said today that it will now offer protein biomarker services, including assay development and validation, and that it has named Mike Pisano, the former head of Protein Research Services, to be CEO of the company.
 
NextGen said its biomarker services are supported by the proteomics know-how that it acquired when it bought PRS in 2006, and by its investments into technologies such as ThermoFisher’s OrbiTrap and its triple quad mass spectrometers.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.